Axis Momentum Fund
The Scheme seeks to provide long-term capital growth from an actively managed diversified portfolio of equity & equity-related securities of companies that exhibit strong momentum. The selection of securities will be based on a quantitative model that will aim to maximize momentum exposure based on various parameter.
Growthvine rating: 2/5 — ranked #139 of 186 in category.
Fund basics
| Category | Equity: Thematic |
|---|
| NAV | ₹8.23 (as of 2026-10-22) |
|---|
| AUM | ₹841 Cr |
|---|
| Expense ratio | 1.99% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Nandik Mallik |
|---|
| Exit load | For units in excess of 10% of the investment, 1% will be charged for redemption within 12 months |
|---|
Performance & risk
| Standard deviation | 0.00% |
|---|
| Max drawdown | −21.74% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Over 5 years, captured 60.9% of NIFTY Alpha 50's upside and 79.8% of its downside.
Market cap allocation
| Large cap | 27.5% |
|---|
| Mid cap | 30.2% |
|---|
| Small cap | 42.3% |
|---|
Concentration
| Top 5 holdings | 23.2% |
|---|
| Top 10 holdings | 39.0% |
|---|
| Total holdings | 48 |
|---|
Top holdings
- RBL Bank Limited — 5.1%
- P N GADGIL JEWELLERS LIMITED — 5.0%
- Laurus Labs Limited — 4.7%
- Navin Fluorine International Limited — 4.4%
- Sai Life Sciences Limited — 4.1%
- Federal Bank Ltd. — 3.4%
- Craftsman Automation Limited — 3.2%
- Radico Khaitan Ltd. — 3.1%
- BSE Ltd. — 3.0%
- GMR Airports Limited — 3.0%
Top sectors
- Banking & Financial — 19.4%
- Industrial Products — 13.1%
- Pharma & Biotech — 9.4%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | −11.9% | Q4 (Bottom) | #151 of 167 |
| 2025 | −4.7% | Q4 (Bottom) | #118 of 132 |